Tradestie Institutional Equity Comparison Engine

ACEP vs ECOR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ECOR Overall Edge

ECOR Captures Institutional Edge (1โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to electroCore, Inc. Common Stock (ECOR) driven by superior Growth & Margin while ACEP counters with relative strength in Momentum & Technical. Fundamentally, ACEP trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ECOR at N/M Forward P/E and -33.1% operating margin (+11.5% YoY). In options structure, ACEP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ACEP N/M vs ECOR N/M Fwd P/E
Growth & Margin Winner ECOR
Op Margin N/A vs -33.1% ยท YoY N/A vs +11.5%
Momentum & Technical Winner ACEP
1Y +25.1% vs -4.0% ยท 52W Pos 65% vs 6%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ACEP US Equity
ACEP
Institutional Equity
$18.92
-1.45% 1D
Market Cap N/A
1M Return -5.81%
1Y Return +25.1%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 51.0 Fund 51.0 Flow 50.0 Mom 70.0
ECOR NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap $47.7M
1M Return -34.01%
1Y Return -3.96%
Forward P/E N/M
Unified AI Score
56.8 / 100 HOLD
Tech 68.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACEP +25.1% ECOR -3.96% Spread: +22.13 pp (ACEP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ACEP TTM Op. Margin: N/A ECOR TTM Op. Margin: -33.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACEP vs ECOR. Trailing 12-month operating profitability (ACEP N/A vs ECOR -33.1%) and valuation multiples (ACEP N/M vs ECOR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACEP (2) vs ECOR (6)
Institutional Metric ACEP ECOR Criterion Row Winner
Market Capitalization Scale N/A $47.7M Larger Scale ECOR
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +11.5% Higher Growth ECOR
Operating Margin (TTM) Profitability N/A -33.1% Higher Margin ECOR
Net Profit Margin Profitability N/A -33.5% Higher Margin ECOR
Return on Equity (ROE) Capital Efficiency N/A -478.7% Higher ROE ECOR
52-Week Range Position Momentum 65% ($15โ€“$21) 6% ($4โ€“$13) Stronger Trend ACEP
Beta / 30D Volatility Risk Regime 0.84ฮฒ ยท 20% Vol 1.52ฮฒ ยท 155% Vol Lower Realized Risk ACEP
Unified Institutional Score Composite Signal 52.6 / 100 (HOLD) 56.8 / 100 (HOLD) Higher Composite ECOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACEP vs ECOR Buy Guide
ACEP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ACEP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ECOR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ECOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACEP nor ECOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.